Opexa Therapeutics Recognizes World MS Day and Will Present Poster With Secondary Progressive Multiple Sclerosis Data at CMSC / ACTRIMS Annual Meeting

Published: May 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing a patient specific T-cell immunotherapy for multiple sclerosis (MS), today honored World MS Day with a renewed commitment to the multiple sclerosis community. Opexa will be sponsoring a booth and will be presenting baseline data from its Immune Monitoring Program in a poster session at the 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) & the Fifth Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) May 29 – June 1 in Orlando, Florida.

Help employers find you! Check out all the jobs and post your resume.

Back to news